FormatLive WebinarTarget audienceThis activity is intended for hematologists/oncologists, advanced practice providers, nurses, psychologists, social w…
This free, three-episode book and web series follows young Olivia as she grapples with a leukemia diagnosis and undergoes treatment. Also available in…
Education Resources
Support Resources
This fact sheet provides information about CMML and JMML diagnoses, treatment, clinical trials, and support resources.
Table of ContentsWhat Is Blood Cancer?Types of Blood CancerLeukemiaAcute vs. Chronic LeukemiaLymphomaMultiple MyelomaMyeloproliferative Neoplasms (MPN…
Blinatumomab will now be available for adults and kids with newly diagnosed B-ALL Rye Brook, N.Y., June 18, 2024 – The U.S. Food and Drug Administrati…
The U.S. Food and Drug Administration has approved pirtobrutinib (Jaypirca™). Pirtobrutinib is the only FDA-approved non-covalent, reversable Bruton’s…
WASHINGTON, February 11, 2025 – As the nation’s largest organization serving the critical needs of blood cancer patients, we are alarmed by recent act…
News Release
Rye Brook, N.Y., May 5, 2022 – The Leukemia & Lymphoma Society (LLS) announced today the intent of Louis J. DeGennaro, Ph.D., president and CEO, to re…
AML risk stratification established by previous studies do not reflect survival outcomes observed in Black patients. Exome sequencing of 100 Black AML…
(Los Angeles, CA July 27, 2019) – The Leukemia & Lymphoma Society’s (LLS) California Southland Chapter celebrated its 2019 Light The Night® with a kic…
LLS would like to thank all of the Chronic Lymphocytic Leukemia patients who contributed to the National Research Registry. Please see the report belo…
_dam_file_119991.jpg?crop=true&keep=c&w=400&h=400)
PhRMA Recognized as 2013 "Titan of Business & Philanthropy" At the Annual Leukemia Ball The Leukemia & Lymphoma Society (LLS) today announced they wil…
(RYE BROOK, N.Y., Dec. 4, 2018) – Burlington Stores and The Leukemia & Lymphoma Society (LLS) joined forces for the 17th consecutive year to help save…
The Beat AML Master Clinical Trial is a paradigm-shifting collaboration to bring precision medicine to patients with acute myeloid leukemia and is the…
Rye Brook, NY (March 21, 2018) - Turning sorrow into action, The Harry T. Mangurian Jr. Foundation, whose namesake died from acute myeloid leukemia (A…
News Release
In November 2022, LLS made an equity investment in Dren Bio to "Support Clinical Development of the DR-01 Program for Rare Leukemia & Lymphoma Indicat…
The Leukemia & Lymphoma Society (LLS) announced today a collaboration with the National Cancer Institute (NCI) and the Children’s Oncology Group (COG)…
This booklet provides information about chronic myeloid leukemia (CML) for people who have CML and their families.
This booklet on CLL includes a glossary of terms and details on what to expect during each stage of diagnosis, treatment, and follow-up care.
The Leukemia & Lymphoma Society (LLS), the global leader and innovator in creating a world without blood cancer, is proud to announce E. Anders Kolb, …
Imagine a community filled with families, friends, and healthcare professionals united to transform the meaning of living with blood cancer. This dive…
Marks the First-Ever Global Pediatric Trial for Menin InhibitorsThe PedAL (Pediatric Acute Leukemia) Master Trial is at the heart of LLS’s Dare to Dre…
News Release
The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.
